SPAG9 and ovarian neoplasm: Results from such IHC analysis confirmed that the JLP-silenced ovarian tumor xenografts exhibited reduced expression of JLP with the concomitant reduction in the expression levels of JNK as well as its phosphorylated activation profile (Figure 6A).